Chakraborty Saikat, Elvezio Vincent, Kaczocha Martin, Rebecchi Mario, Puopolo Michelino
Department of Anesthesiology, Stony Brook Medicine, Stony Brook, NY, 11794, USA.
Present address: Department of Biochemistry, Rush University Medical Center, Cohn Research Building, 1735 W. Harrison St., Chicago, IL, 60612, USA.
J Physiol. 2017 Apr 15;595(8):2639-2660. doi: 10.1113/JP273455. Epub 2017 Feb 22.
The transient receptor potential vanilloid type 1 (TRPV1) receptor is a polymodal molecular integrator in the pain pathway expressed in Aδ- and C-fibre nociceptors and is responsible for the thermal hyperalgesia associated with inflammatory pain. Noradrenaline strongly inhibited the activity of TRPV1 channels in dorsal root ganglia neurons. The effect of noradrenaline was reproduced by clonidine and antagonized by yohimbine, consistent with contribution of α2 adrenergic receptors. The inhibitory effect of noradrenaline on TRPV1 channels was dependent on calcium influx and linked to calcium/calmodulin-dependent protein kinase II. In spinal cord slices, clonidine reduced the frequency of capsaicin-induced miniature EPSCs in the presence of tetrodotoxin and ω-conotoxin-MVIIC, consistent with inhibition of presynaptic TRPV1 channels by α2 adrenergic receptors. We suggest that modulation of presynaptic TRPV1 channels in nociceptive neurons by descending noradrenergic inputs may constitute a mechanism for noradrenaline to modulate incoming noxious stimuli in the dorsal horn of the spinal cord.
The transient receptor potential vanilloid type 1 (TRPV1) receptor is a well-known contributor to nociceptor excitability. To address whether noradrenaline can down-regulate TRPV1 channel activity in nociceptors and reduce their synaptic transmission, the effects of noradrenaline and clonidine were tested on the capsaicin-activated current recorded from acutely dissociated small diameter (<27 μm) dorsal root ganglia (DRG) neurons and on miniature (m)EPSCs recorded from large lamina I neurons in horizontal spinal cord slices. Noradrenaline or clonidine inhibited the capsaicin-activated current by ∼60%, and the effect was reversed by yohimbine, confirming that it was mediated by activation of α2 adrenergic receptors. Similarly, clonidine reduced the frequency of capsaicin-induced mEPSCs by ∼60%. Inhibition of capsaicin-activated current by noradrenaline was mediated by GTP binding proteins, and was highly dependent on calcium influx. The inhibitory effect of noradrenaline on the capsaicin-activated current was not affected either by blocking the activity of protein kinase A with H89, or by blocking the activity of protein kinase C with bisindolylmaleimide II. In contrast, when the calcium/calmodulin-dependent protein kinase II (CaMKII) was blocked with KN-93, the inhibitory effect of noradrenaline on the capsaicin-activated current was greatly reduced, suggesting that activation of adrenergic receptors in DRG neurons is preferentially linked to CaMKII activity. We suggest that modulation of TRPV1 channels by noradrenaline in nociceptive neurons is a mechanism whereby noradrenaline may suppress incoming noxious stimuli at the primary synaptic afferents in the dorsal horn of the spinal cord.
瞬时受体电位香草酸受体1(TRPV1)是疼痛通路中的一种多模式分子整合器,表达于Aδ和C纤维伤害性感受器中,负责与炎性疼痛相关的热痛觉过敏。去甲肾上腺素强烈抑制背根神经节神经元中TRPV1通道的活性。可乐定可重现去甲肾上腺素的作用,而育亨宾可拮抗该作用,这与α2肾上腺素能受体的作用一致。去甲肾上腺素对TRPV1通道的抑制作用依赖于钙内流,并与钙/钙调蛋白依赖性蛋白激酶II相关。在脊髓切片中,可乐定在存在河豚毒素和ω-芋螺毒素-MVIIC的情况下降低了辣椒素诱导的微小兴奋性突触后电流(mEPSCs)的频率,这与α2肾上腺素能受体对突触前TRPV1通道的抑制作用一致。我们认为,下行去甲肾上腺素能输入对伤害性神经元中突触前TRPV1通道的调节可能构成去甲肾上腺素调节脊髓背角传入有害刺激的一种机制。
瞬时受体电位香草酸受体1(TRPV1)是伤害性感受器兴奋性的一个众所周知的促成因素。为了探讨去甲肾上腺素是否能下调伤害性感受器中TRPV1通道的活性并减少其突触传递,研究了去甲肾上腺素和可乐定对急性分离的小直径(<27μm)背根神经节(DRG)神经元记录的辣椒素激活电流以及水平脊髓切片中I层大神经元记录的微小(m)EPSCs的影响。去甲肾上腺素或可乐定抑制辣椒素激活电流约60%,且该作用可被育亨宾逆转,证实其由α2肾上腺素能受体激活介导。同样,可乐定使辣椒素诱导的mEPSCs频率降低约60%。去甲肾上腺素对辣椒素激活电流的抑制作用由GTP结合蛋白介导,且高度依赖于钙内流。用H89阻断蛋白激酶A的活性或用双吲哚马来酰亚胺II阻断蛋白激酶C的活性,均不影响去甲肾上腺素对辣椒素激活电流的抑制作用。相反,用KN-93阻断钙/钙调蛋白依赖性蛋白激酶II(CaMKII)时,去甲肾上腺素对辣椒素激活电流的抑制作用大大降低,表明DRG神经元中肾上腺素能受体的激活优先与CaMKII活性相关。我们认为,去甲肾上腺素对伤害性神经元中TRPV1通道的调节是去甲肾上腺素可能在脊髓背角初级突触传入处抑制传入有害刺激的一种机制。